New York State Common Retirement Fund Biocryst Pharmaceuticals Inc Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 55,598 shares of BCRX stock, worth $437,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,598
Previous 55,598
-0.0%
Holding current value
$437,000
Previous $423,000
1.18%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BCRX
# of Institutions
277Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$172 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$157 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$93.3 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$71.4 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$64 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.46B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...